VIGILVESTLibrary
← Library

IDEXX LABORATORIES INC /DE

IDXX
SEC CIK 874716Price charts ↗
Writing the earnings story…

Financials

Revenue+14.3% YoY
$1.14B
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
Net Income+14.7% YoY
$278.4M
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
EPS (diluted)+17.2% YoY
$3.47
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
Gross Margin+1.5% YoY
63.4%
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
Quarter endingRevenueNet incomeEPS
Mar 2026$1.14B$278.4M$3.47
Sep 2025$1.11B$274.6M$3.4
Jun 2025$1.11B$294.0M$3.63
Mar 2025$998.4M$242.7M$2.96
Sep 2024$975.5M$232.8M$2.8
Jun 2024$1.00B$203.3M$2.44
Mar 2024$964.1M$235.6M$2.81
Sep 2023$915.5M$212.2M$2.53

Annual revenue

FY21FY22FY23FY24FY25

Source filings

Download the original reports from the SEC. A 10-Q is the quarterly update; a 10-K is the detailed annual report.

Glossary

Revenue
Net income
EPS
Gross margin
Net margin
Fiscal year

Hover any underlined term for its definition.